Brief: Consun Pharmaceutical Group Sees Decrease Of About 70% To 80% In FY19 Profit Attributable
Jan 9 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK :
* EXPECTED THAT PROFIT ATTRIBUTABLE FOR FY2019 WOULD RECORD
A
DECREASE OF APPROXIMATELY 70% TO 80%
* EXPECTED RESULT DUE TO DECREASE IN SALES REVENUE OF YULIN
PHARMACEUTICAL SEGMENT
* EXPECTED TO RECORD DECREASE OF JUST LESS THAN 10% IN TOTAL
SALES
REVENUE FOR FY2019 AS COMPARED TO THAT FOR FY2018
Source text for Eikon: ID:nHKS6ZSVY3
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director